Zim Laboratories Ltd

NSE
ZIMLAB •
BUY

1W Return

-%

1M Return

-%

6M Return

-%

1Y Return

-%

3Y Return

-%

Start SIP in Zim Laboratories Ltd
Stock Performance
52 Week Low - High
Today’s Low - High

Open

Prev. Close

Total Traded Value

View details of Market Depth
Fundamental

Market Cap (in crs)

Face Value

Turnover (in lacs)

Key Metrics
Qtr Change %
25.47% Fall from 52W High
-3.5
TTM PE Ratio
Above industry Median
33.6
Price to Book Ratio
Below industry Median
2.8
Dividend yield 1yr %
0
TTM PEG Ratio
PEG TTM is negative
-1
RSI
RSI is mid-range
53.3
MFI
MFI is mid-range
70

Zim Laboratories Ltd Key Financials

*All values are in ₹ Cr.

Zim Laboratories Ltd shareholding Pattern

Promoter
33.3%
Public
66.7%

Zim Laboratories Ltd Technical Analysis

Moving Averages Analysis
Moving Averages Analysis
Current Price
Bullish Moving Averages
10
Bearish Moving Averages
6
5Day EMA
113.20
10Day EMA
112.30
12Day EMA
112.00
20Day EMA
111.50
26Day EMA
111.50
50Day EMA
112.30
100Day EMA
113.40
200Day EMA
110.40
Delivery & Volume
Resistance & Support
113.42
Pivot
Resistance
First Resistance
115.23
Second Resistance
117.37
Third Resistance
119.18
Support
First Support
111.28
Second support
109.47
Third Support
107.33
Relative Strength Index
53.32
Money Flow Index
69.98
MACD
0.53
MACD Signal
-0.21
Average True Range
4.59
Average Directional Index
12.19
Rate of Change (21)
3.10
Rate of Change (125)
-8.79

Zim Laboratories Ltd Company background

Founded in: 1984
Managing director: Anwar S Daud
Zim Laboratories Ltd was incorporated in February, 1984 under the name and style of Zim Laboratories Private Limited in the State of Maharashtra. The Company became a Public Limited Company through fresh Certificate of Incorporation issued by the Registrar of Companies, Maharashtra, Mumbai. The Company is engaged in the manufacturing of formulation on drugs and pre formulation ingredients in India and marketing and selling these within and outside India. The Pharma Industry is dominated by Multinationals, Large Indian companies and in the lower end of the market large number of units mainly in the SSI sector.During the year 201920, ZIM Health Technologies Limited was acquired thereby resulting as a wholly owned subsidiary of the company . SIA ZIM Laboratories Limited got incorporated as a wholly owned subsidiary in Latvia.In 2023, the Company launched Thinoral (Patented Oral Thin Film technology) as an alternate drug delivery platform across RoW/Pharmerging Markets and EU.
Read More

Zim Laboratories Ltd FAQs

Zim Laboratories Ltd shares are currently priced at 113.4 on NSE and 113.1 on BSE as of 2/22/2024 12:00:00 AM. Please be aware that stock prices are subject to continuous fluctuations due to various factors.

The past 1-year return of Zim Laboratories Ltd [ZIMLAB] share was 52.83. The Zim Laboratories Ltd [ZIMLAB] share hit a 1-year low of Rs. 68.05 and a 1-year high of Rs. 152.7.

The market cap of Zim Laboratories Ltd is Rs. 552.55 Cr. as of 2/22/2024 12:00:00 AM.

The PE ratios of Zim Laboratories Ltd is 34.47 as of 2/22/2024 12:00:00 AM.

The PB ratios of Zim Laboratories Ltd is 2.51 as of 2/22/2024 12:00:00 AM

You can easily buy Zim Laboratories Ltd shares in Kotak Securities by opening a demat account and getting the KYC documents verified online.

Open Demat Account
or Resume your Application
+91 -

personImage